New Vaccine for Swine Fever Using E. coli
Author Information
Author(s): Zhou Bin, Liu Ke, Jiang Yan, Wei Jian-Chao, Chen Pu-Yan
Primary Institution: Nanjing Agricultural University
Hypothesis
Can multiple linear B-cell epitopes of classical swine fever virus glycoprotein E2 expressed in E. coli induce a protective immune response in pigs?
Conclusion
The study found that the multiple epitope vaccine induced a strong immune response and provided complete protection against classical swine fever virus in pigs.
Supporting Evidence
- All epitope-vaccinated pigs mounted an anamnestic response after booster vaccination.
- The multiple epitope vaccine provided complete protection against CSFV infection.
- Control pigs exhibited severe clinical symptoms and had to be euthanized.
Takeaway
Scientists created a new vaccine for pig swine fever using tiny pieces of the virus, and it worked really well to keep the pigs safe.
Methodology
The study involved immunizing 15 piglets with two B-cell linear epitopes expressed in E. coli and then challenging them with a virulent strain of CSFV.
Limitations
The study did not explore the long-term immunity provided by the vaccine.
Participant Demographics
15 specified-pathogen-free (SPF) piglets, 6 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website